Bucolome

CAS No. 841-73-6

Bucolome( Paramidin | Paramidine | Bucolomum | 5-Butyl-1-cyclohexylbarbituric acid | Bucolom )

Catalog No. M26078 CAS No. 841-73-6

Bucolome is a CYP2C9 inhibitor used as an anti-inflammatory agent or uricosuric agent.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 136 In Stock
5MG 153 In Stock
10MG 224 In Stock
25MG 337 In Stock
50MG 462 In Stock
100MG 631 In Stock
200MG 849 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Bucolome
  • Note
    Research use only, not for human use.
  • Brief Description
    Bucolome is a CYP2C9 inhibitor used as an anti-inflammatory agent or uricosuric agent.
  • Description
    Bucolome is a CYP2C9 inhibitor used as an anti-inflammatory agent or uricosuric agent.(In Vitro):In studies with recombinant human cytochrome P-450 2C9 and liver microsomes, Bucolome is a potent mixed-type inhibitor for (S)-warfarin 7-hydroxylation, with Ki of 8.2 and 20.2 microM, respectively.
  • In Vitro
    Bucolome is a potent mixed-type inhibitor for (S)-warfarin 7-hydroxylation, with Ki of 8.2 and 20.2 μM, respectively.
  • In Vivo
    ——
  • Synonyms
    Paramidin | Paramidine | Bucolomum | 5-Butyl-1-cyclohexylbarbituric acid | Bucolom
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    841-73-6
  • Formula Weight
    266.341
  • Molecular Formula
    C14H22N2O3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CCCCC1C(=O)NC(=O)N(C2CCCCC2)C1=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Williams WG, et, al. 2-Tridecanone: A Naturally Occurring Insecticide from the Wild Tomato Lycopersicon hirsutum f.glabratum. Science. 1980 Feb 22;207(4433):888-9.
molnova catalog
related products
  • 2-Butenoic acid, 2-m...

    Anti-osteoporosis agent-2 (Compound 10) is an anti-osteoporosis agent. Anti-osteoporosis agent-2 inhibits differentiation on osteoclast induced by RANKL.

  • RET-IN-1

    RET-IN-1 is a RET kinase inhibitor extracted from patent WO2018071447A1, Compound Example 552.

  • MYF-01-37

    MYF-01-37 is a novel covalent TEAD inhibitor.